What does Dr. Edward Camerlynck, huisarts do?

Dr. Edward Camerlynck, huisarts is a general practice in Merelbeke-Melle. Private Limited, started on 1 December 2016, 2 establishments.

What is the address of Dr. Edward Camerlynck, huisarts?

The registered office of Dr. Edward Camerlynck, huisarts is located at Burg. Maenhautstraat 28, 9820 Merelbeke-Melle.

Is Dr. Edward Camerlynck, huisarts still active?

Yes. According to the CBE (18 September 2026) Dr. Edward Camerlynck, huisarts is active, legal situation “Normale toestand”, started on 1 December 2016.

Is Dr. Edward Camerlynck, huisarts registered on Peppol?

Yes, Dr. Edward Camerlynck, huisarts is registered on the Peppol network with ID 0208:0666859756.

What is the enterprise number of Dr. Edward Camerlynck, huisarts?

The enterprise number of Dr. Edward Camerlynck, huisarts is BE0666859756.

When was Dr. Edward Camerlynck, huisarts founded?

Dr. Edward Camerlynck, huisarts was founded on 1 December 2016.

Who are the directors of Dr. Edward Camerlynck, huisarts?

According to the 2025 annual accounts, the directors of Dr. Edward Camerlynck, huisarts are: Edward Camerlynck.

Is Dr. Edward Camerlynck, huisarts a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 December 2016; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 2 establishments in the CBE.

How much profit did Dr. Edward Camerlynck, huisarts make in 2025?

Dr. Edward Camerlynck, huisarts posted a profit after taxes of € 100,251 in financial year 2025.

What is the revenue of Dr. Edward Camerlynck, huisarts?

As a small company, Dr. Edward Camerlynck, huisarts is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 143,269.

Dr. Edward Camerlynck, huisarts (Private Limited)

Dossier Dr. Edward Camerlynck, huisarts, printed on 18 September 2026 from databakkes.be/en/0666859756/dr-edward-camerlynck-huisarts. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Edward Camerlynck, huisarts from Merelbeke-Melle, company number BE0666859756, closed financial year 2025 with a result of € 100,251 after tax. For that financial year Dr. Edward Camerlynck, huisarts recorded a gross margin of € 143,269 and equity of € 309,985. Compared with financial year 2024, the result moved from € 144,116 to € 100,251. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Growing

€ 309,985

▲ 47% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 100,251

▼ 30% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 251,840

▲ 69% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 1,666 paid out

2 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 30,134

▼ 24% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 730

▼ 50% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 2,525

▼ 82% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 116,074 Gross margin 2022: € 116,074 First fiscal year in the series	€ 146,318 Gross margin 2023: € 146,318 ▲ 26% vs 2022 (€ 116,074) Favourable step	€ 197,306 Gross margin 2024: € 197,306 ▲ 35% vs 2023 (€ 146,318) Favourable step	€ 143,269 Gross margin 2025: € 143,269 ▼ 27% vs 2024 (€ 197,306) Unfavourable step	▼ 27%
Profit after taxes	€ 88,923 Profit after taxes 2022: € 88,923 First fiscal year in the series	€ 111,241 Profit after taxes 2023: € 111,241 ▲ 25% vs 2022 (€ 88,923) Favourable step	€ 144,116 Profit after taxes 2024: € 144,116 ▲ 30% vs 2023 (€ 111,241) Favourable step	€ 100,251 Profit after taxes 2025: € 100,251 ▼ 30% vs 2024 (€ 144,116) Unfavourable step	▼ 30%
Equity	€ 185,300 Equity 2022: € 185,300 First fiscal year in the series	€ 68,950 Equity 2023: € 68,950 ▼ 63% vs 2022 (€ 185,300) Unfavourable step	€ 211,400 Equity 2024: € 211,400 ▲ 207% vs 2023 (€ 68,950) Favourable step	€ 309,985 Equity 2025: € 309,985 ▲ 47% vs 2024 (€ 211,400) Favourable step	▲ 47%
Total debts	€ 100,008 Total debts 2022: € 100,008 First fiscal year in the series	€ 90,878 Total debts 2023: € 90,878 ▼ 9% vs 2022 (€ 100,008) Favourable step	€ 42,004 Total debts 2024: € 42,004 ▼ 54% vs 2023 (€ 90,878) Favourable step	€ 18,898 Total debts 2025: € 18,898 ▼ 55% vs 2024 (€ 42,004) Favourable step	▼ 55%
Cash	€ 31,689 Cash 2022: € 31,689 First fiscal year in the series	€ 79,493 Cash 2023: € 79,493 ▲ 151% vs 2022 (€ 31,689) Favourable step	€ 148,657 Cash 2024: € 148,657 ▲ 87% vs 2023 (€ 79,493) Favourable step	€ 251,840 Cash 2025: € 251,840 ▲ 69% vs 2024 (€ 148,657) Favourable step	▲ 69%
Retained profit	€ 166,700 Retained profit 2022: € 166,700 First fiscal year in the series	€ 50,350 Retained profit 2023: € 50,350 ▼ 70% vs 2022 (€ 166,700) Unfavourable step	€ 192,800 Retained profit 2024: € 192,800 ▲ 283% vs 2023 (€ 50,350) Favourable step	€ 291,385 Retained profit 2025: € 291,385 ▲ 51% vs 2024 (€ 192,800) Favourable step	▲ 51%
Dividend	€ 88,923 Dividend 2022: € 88,923 First fiscal year in the series	€ 227,591 Dividend 2023: € 227,591 ▲ 156% vs 2022 (€ 88,923) Unchanged	€ 1,666 Dividend 2024: € 1,666 ▼ 99% vs 2023 (€ 227,591) Unchanged	€ 1,666 Dividend 2025: € 1,666 Unchanged (€ 1,666) Unchanged
Bank debt	€ 7,033 Bank debt 2022: € 7,033 First fiscal year in the series	€ 0 Bank debt 2023: € 0 ▼ 100% vs 2022 (€ 7,033) Favourable step	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 285,308 Balance sheet total 2022: € 285,308 First fiscal year in the series	€ 159,828 Balance sheet total 2023: € 159,828 ▼ 44% vs 2022 (€ 285,308) Unchanged	€ 253,405 Balance sheet total 2024: € 253,405 ▲ 59% vs 2023 (€ 159,828) Unchanged	€ 328,883 Balance sheet total 2025: € 328,883 ▲ 30% vs 2024 (€ 253,405) Unchanged	▲ 30%

Key figures of Dr. Edward Camerlynck, huisarts, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Edward Camerlynck, huisarts?

What happened at Dr. Edward Camerlynck, huisarts in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2026 New annual accounts for financial year 2025: profit of € 100,251 (▼ 30% vs 2024). filed late Source: NBB ↗
Dec 1, 2016 New establishment in Merelbeke-Melle. KBO
Dec 1, 2016 New establishment in Merelbeke-Melle. KBO
Dec 1, 2016 Start of the company according to the CBE. KBO

In short

From € 88,923 profit in 2022 to € 100,251 profit in 2025.

Paid € 127,515 in corporate taxes since 2022.

Best year ever: 2024, with € 144,116 profit.

Paid out € 319,847 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Edward Camerlynck, huisarts? We notify you, reason included.

Follow Dr. Edward Camerlynck, huisarts

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Edward Camerlynck

Dr. Edward Camerlynck, huisarts

Behind Dr. Edward Camerlynck, huisarts is Edward Camerlynck.

See the full network in the app

Directors

According to the 2025 annual accounts

Edward Camerlynck

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Burg. Maenhautstraat 28

9820 Merelbeke-Melle

2.259.651.028

Gaversesteenweg 254

9820 Merelbeke-Melle

Active since 1 December 2016

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0666.859.756

VAT number

BE 0666.859.756

Registered office

Burg. Maenhautstraat 28, 9820 Merelbeke-Melle

Names & denominations

Dr. Edward Camerlynck, huisarts

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

1 December 2016

Peppol

Active · Active since 28 Aug 2026

Activities · NACE

Activiteiten van huisartspraktijken

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Activiteiten van medisch specialisten

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

View on CBE Public ↗ Annual accounts (NBB) ↗

Dr. Edward Camerlynck, huisarts

Financials

What happened to Dr. Edward Camerlynck, huisarts?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions